Home » Medical Devices » Diabetes Care Devices Market

Diabetes Care Devices Market By Type (Monitoring, Delivery); By Monitoring Devices (Continuous Monitoring Devices, Lancets, Test Strips, Self-Monitoring Devices, Monitoring Devices 5); By Delivery Devices (Insulin Pumps, Pens, Syringes, Needles, Delivery Devices); By Indication (Diabetes Type I, Diabetes Type II, Gestational Diabetes, Indication 4, Indication 5); By End-Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 63466 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Diabetes Care Devices Market Size 2023  USD 31,762.94 Million
Diabetes Care Devices Market, CAGR  5.37%
Diabetes Care Devices Market Size 2032  USD 35,638.02 Million

Market Overview

The global Diabetes Care Devices Market is projected to grow from USD 31,762.94 million in 2023 to USD 35,638.02 million by 2032, registering a CAGR of 5.37% during the forecast period.

The global diabetes care devices market is driven by the increasing prevalence of diabetes worldwide, advancements in technology, and the growing adoption of home care solutions. As the global diabetic population continues to rise, the demand for innovative devices, such as glucose monitoring systems, insulin pumps, and continuous glucose monitoring (CGM) systems, has surged. The shift toward personalized healthcare and remote monitoring solutions is further propelling market growth, as these devices offer convenience, accuracy, and real-time data for better disease management. Additionally, the growing awareness of diabetes prevention and management, supported by government initiatives, is fostering the adoption of diabetes care devices. Technological advancements in miniaturization, connectivity, and integration with mobile apps and wearables are enhancing patient engagement and improving treatment outcomes. These factors, combined with the rising preference for non-invasive monitoring methods, are expected to drive significant growth in the diabetes care devices market.

The global diabetes care devices market is witnessing significant growth across various regions, driven by increasing diabetes prevalence and advancements in technology. North America holds a dominant position, primarily due to a high adoption rate of advanced diabetes care devices, including continuous glucose monitoring systems and insulin pumps. The presence of key players such as Abbott Laboratories, Dexcom, and Medtronic further strengthens the market in this region. Europe follows closely, with an emphasis on innovation in diabetes care solutions and a growing elderly population. In emerging markets, particularly in Asia-Pacific, the demand for affordable diabetes care devices is rising, with key players such as Roche, Novo Nordisk, and Terumo Corporation expanding their presence. These players are focusing on enhancing their product portfolios and increasing accessibility to cater to the diverse needs of the diabetic population worldwide.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The global diabetes care devices market was valued at USD 31,762.94 million in 2023 and is expected to reach USD 35,638.02 million by 2032, growing at a CAGR of 5.37% from 2024 to 2032.
  • Increasing prevalence of diabetes, particularly in aging populations, is driving the demand for diabetes care devices.
  • Technological advancements such as continuous glucose monitoring (CGM) systems and insulin pumps are further boosting market growth.
  • Lack of reimbursement policies in several regions poses a barrier to market expansion, limiting device accessibility.
  • Strict regulatory frameworks and approval processes for new diabetes care devices are challenging for manufacturers.
  • North America holds the largest market share, driven by high demand for advanced diabetes care solutions.
  • The Asia-Pacific region is witnessing significant growth, with a rising demand for affordable diabetes care devices and increasing healthcare investments.

Market Drivers

Rising Prevalence of Diabetes

The global rise in diabetes cases is primarily driven by an aging population, sedentary lifestyles, unhealthy diets, and genetic predisposition. As populations age, the incidence of diabetes increases, with older individuals being more prone to developing type 2 diabetes. For instance, the International Diabetes Federation reports that the number of people living with diabetes is projected to rise to 783 million by 2045, with aging being a significant contributing factor. Additionally, modern lifestyles characterized by physical inactivity and poor dietary habits, such as high sugar and fat intake, are contributing significantly to the rising prevalence. Certain populations are also genetically predisposed to diabetes, further exacerbating the situation. These factors collectively drive the demand for effective diabetes care solutions.

Technological Advancements

Technological innovation plays a crucial role in advancing diabetes care. Devices like Continuous Glucose Monitoring (CGM) systems provide real-time data, allowing patients to track glucose levels and make timely adjustments to their treatment plans. For instance, the American Diabetes Association highlights that CGM systems and insulin pumps have significantly improved glycemic control and reduced the risk of hypoglycemia. Insulin pumps offer precise insulin delivery, improving glycemic control and reducing the risk of hypoglycemia. Furthermore, smart insulin pens have enhanced convenience by offering features such as dose reminders, automatic dose calculations, and smartphone connectivity. These advancements are improving patient outcomes and enhancing the overall management of diabetes.

Increased Awareness and Early Detection

Increased awareness and early detection have significantly contributed to better diabetes management. Public health campaigns spearheaded by governments and healthcare organizations are effectively promoting awareness of diabetes risk factors and prevention. Early diagnosis plays a critical role in improving management outcomes, as timely intervention can prevent complications and enhance the quality of life for patients. This growing awareness is helping individuals take proactive steps toward managing their condition, driving the demand for advanced diabetes care devices.

Government Initiatives and Reimbursement Policies

Government initiatives and favorable reimbursement policies are further supporting the growth of the diabetes care devices market. Regulatory frameworks that facilitate the approval of innovative diabetes care solutions help accelerate the development and adoption of new devices. For instance, the Indian government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) focuses on early diagnosis and management of diabetes. Additionally, government-sponsored healthcare programs and private insurance plans that cover diabetes care devices reduce financial barriers, making advanced solutions more accessible to a broader population. These initiatives are crucial for expanding market growth and ensuring widespread adoption of diabetes management technologies.

Market Trends

Technological Advancements and Integration with Telehealth

Technological innovations are transforming diabetes care by offering more sophisticated and user-friendly solutions. Continuous Glucose Monitoring (CGM) systems now provide real-time glucose data, predictive alerts, and improved accuracy, empowering patients to manage their condition more effectively. Insulin pumps have evolved with advanced features such as remote monitoring, automated insulin delivery, and personalized dosing algorithms, enhancing convenience and glycemic control. Smart insulin pens are also gaining traction, offering features like dose reminders, automatic dose calculations, and smartphone connectivity, improving treatment adherence. Additionally, the integration of diabetes care devices with telehealth platforms is revolutionizing patient management. Remote monitoring solutions allow healthcare providers to track glucose levels and other vital signs in real-time, ensuring timely interventions. Telehealth consultations offer patients easy access to care, particularly in underserved or remote areas, reducing healthcare disparities. This seamless combination of advanced technology and virtual care is improving diabetes management outcomes while enhancing patient satisfaction.

Personalized Medicine, Wearable Technology, and Emerging Market Growth

The focus on personalized medicine and wearable technology is significantly shaping the diabetes care devices market. With data-driven insights from CGM systems and AI-powered analytics, healthcare providers can design tailored treatment plans that cater to individual patient needs. AI and machine learning technologies analyze patient data to identify trends, predict complications, and enable proactive interventions. Wearable technology, such as smartwatches and fitness trackers, is increasingly integrated with diabetes care devices, offering patients a holistic view of their health. Discreet wearable sensors for glucose monitoring are becoming popular due to their convenience and non-invasive nature. For instance, government programs in countries like India are focusing on early diagnosis and management of diabetes to improve health outcomes. Simultaneously, emerging markets are witnessing robust growth in diabetes care devices due to rising healthcare spending and government initiatives aimed at improving access to advanced medical technologies. As the middle class expands in these regions, the demand for reliable and user-friendly devices is surging. Devices with intuitive interfaces and enhanced accuracy are gaining preference, emphasizing the importance of patient-centric solutions in the global diabetes care landscape.

Market Challenges Analysis

High Cost and Complex Accessibility Barriers

The high cost of advanced diabetes care devices remains a significant challenge for market growth. Devices such as Continuous Glucose Monitoring (CGM) systems and insulin pumps, while innovative and highly effective, often come with steep price tags, making them less accessible to a large segment of the population. For instance, an ADA study found that many patients find CGMs financially out of reach. Limited reimbursement policies further exacerbate this issue, as insurance coverage varies widely across regions. In some countries, patients must bear the majority of the costs, discouraging the adoption of advanced solutions. These financial barriers disproportionately affect individuals in low- and middle-income regions, hindering equitable access to essential diabetes management tools. Additionally, the lack of comprehensive reimbursement frameworks slows down the widespread adoption of innovative technologies, limiting their impact on improving diabetes care globally.

Regulatory, Technical, and Infrastructure Challenges

Navigating the complex regulatory landscape poses another critical hurdle for manufacturers in the diabetes care devices market. Stringent regulatory requirements for device approval, coupled with varying standards across countries, increase development costs and delay market entry. These challenges are particularly pronounced for companies seeking to operate in multiple regions, where compliance with diverse guidelines requires significant resources. Furthermore, patient adherence and user experience issues also impact market growth. Devices with complex interfaces can overwhelm users, necessitating extensive training and support. Problems like sensor inaccuracies or skin discomfort from wearable devices can compromise patient trust and adherence, negatively affecting glycemic control. Data security and privacy concerns add another layer of complexity. As devices become more connected, they are vulnerable to cyberattacks and data breaches. Adhering to evolving data privacy regulations presents an ongoing challenge for manufacturers and healthcare providers. Finally, in emerging markets, inadequate healthcare infrastructure and unreliable supply chains hinder the effective deployment and use of diabetes care devices. These regions often lack the resources needed to train patients and maintain consistent device availability, limiting market penetration despite growing demand.

Market Opportunities

Expanding Access in Emerging Markets

Emerging markets present significant growth opportunities for the global diabetes care devices industry, driven by increasing healthcare expenditure and a growing middle-class population. Governments in these regions are implementing initiatives to improve healthcare infrastructure and access to advanced medical devices. As awareness about diabetes prevention and management grows, the demand for affordable and user-friendly solutions is rising. Manufacturers focusing on cost-effective devices tailored to the unique needs of these markets can capture a substantial share of the untapped population. Furthermore, partnerships with local distributors and healthcare providers can enhance market reach and streamline supply chains in these regions, addressing logistical challenges effectively.

Advancements in Personalized and Connected Healthcare

The shift toward personalized medicine and connected healthcare offers lucrative opportunities for innovation in diabetes care devices. Continuous Glucose Monitoring (CGM) systems and smart insulin delivery devices, integrated with artificial intelligence (AI) and machine learning, are enabling real-time, data-driven insights for tailored diabetes management. Wearable technology and smartphone applications are enhancing patient engagement and adherence by providing intuitive, user-friendly interfaces and seamless data sharing with healthcare professionals. Additionally, the growing acceptance of telehealth and remote monitoring solutions is expanding the scope of diabetes care beyond traditional clinical settings. Manufacturers leveraging these advancements to develop integrated ecosystems of devices and digital platforms can cater to the increasing demand for convenient, accurate, and personalized diabetes management tools. This trend is expected to drive innovation and expand the adoption of diabetes care devices globally.

Market Segmentation Analysis:

By Type:

The global diabetes care devices market is primarily segmented into two main types: Monitoring and Delivery devices. Monitoring devices are designed to help individuals track and manage their glucose levels, while delivery devices focus on administering insulin or other treatments. The Monitoring segment is expected to dominate the market due to the growing demand for real-time glucose tracking and the increasing prevalence of diabetes worldwide. Continuous Monitoring Devices, such as Continuous Glucose Monitoring (CGM) systems, provide real-time data, empowering patients to manage their diabetes more effectively. Lancets and test strips remain essential components for self-monitoring, while Self Monitoring Devices offer comprehensive solutions for home-based diabetes management. The Monitoring Devices 5 segment, which includes various advanced monitoring technologies, is also gaining momentum, contributing to the overall growth of the market.

By Monitoring Devices:

Within the Monitoring devices category, several segments cater to specific needs of diabetes patients. Continuous Monitoring Devices, including CGM systems, are gaining popularity for their ability to provide continuous, real-time glucose data, helping to optimize treatment plans. Lancets and Test Strips continue to be widely used, offering cost-effective and simple ways for patients to monitor their blood glucose levels. The Self Monitoring Devices segment is expected to see significant growth as consumers increasingly seek convenient and accessible solutions for managing their condition at home. Furthermore, the Monitoring Devices 5 segment is expected to see innovation in technologies that offer improved accuracy and patient experience, driving further demand for advanced diabetes care solutions. The combined impact of these segments will continue to expand the global diabetes care devices market in the coming years.

Segments:

Based on Type:

  • Monitoring
  • Delivery

Based on Monitoring Devices:

  • Continuous Monitoring Devices
  • Lancets
  • Test Strips
  • Self Monitoring Devices
  • Monitoring Devices 5

Based on Delivery Devices:

  • Insulin Pumps
  • Pens
  • Syringes
  • Needles
  • Delivery Devices

Based on Indication:

  • Diabetes Type I
  • Diabetes Type II
  • Gestational Diabetes
  • Indication 4
  • Indication 5

Based on End-Users:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on the Geography:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Russia
    • Belgium
    • Netherlands
    • Austria
    • Sweden
    • Poland
    • Denmark
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Thailand
    • Indonesia
    • Vietnam
    • Malaysia
    • Philippines
    • Taiwan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Peru
    • Chile
    • Colombia
    • Rest of Latin America
  • Middle East
    • UAE
    • KSA
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East
  • Africa
    • Egypt
    • Nigeria
    • Algeria
    • Morocco
    • Rest of Africa

Regional Analysis

North America

North America holds a dominant share in the global diabetes care devices market, accounting for approximately 40% of the total market revenue in 2023. This leadership is primarily driven by the high prevalence of diabetes, the increasing adoption of advanced monitoring and delivery devices, and significant healthcare spending in the region. The United States, in particular, plays a key role in this market, with robust healthcare infrastructure and a strong focus on innovation in diabetes care technologies. Continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens have seen widespread adoption due to their effectiveness in managing diabetes. Additionally, the region benefits from favorable reimbursement policies and government initiatives aimed at improving diabetes management. With an aging population and rising lifestyle-related diseases, the demand for diabetes care devices is expected to continue growing in North America, further consolidating its market share. The presence of leading medical device manufacturers in the U.S. and Canada also contributes to the region’s growth, along with strategic partnerships and technological advancements.

Asia-Pacific

The Asia-Pacific region currently holds a smaller market share compared to North America, its rapid economic development, increasing urbanization, and rising diabetes prevalence are driving the adoption of advanced diabetes care technologies. In 2023, the APAC market share was estimated to be around 25%. Countries like China and India are witnessing a surge in diabetes cases due to lifestyle changes, such as poor dietary habits and reduced physical activity. In response to this, healthcare systems in these nations are increasingly investing in diabetes care devices, such as glucose monitoring systems and insulin delivery devices. The government initiatives aimed at expanding healthcare access, coupled with growing healthcare spending, are contributing to the market’s growth. Furthermore, the expanding middle class and rising disposable income in emerging markets such as India, Indonesia, and the Philippines are further bolstering the demand for high-quality, affordable diabetes care solutions. As awareness and accessibility improve, the APAC region is poised to become a key player in the global diabetes care devices market.

Key Player Analysis

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Terumo Corporation
  • Company 11
  • Company 12
  • Company 13
  • Company 14

Competitive Analysis

The global diabetes care devices market is highly competitive, with several key players leading the industry. Abbott Laboratories, ACON Laboratories, Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, and Terumo Corporation are prominent companies driving innovation and market growth. Companies in this space focus on continuous advancements in technology, particularly in the areas of continuous glucose monitoring (CGM), insulin pumps, and smart insulin pens. Innovation is driven by the increasing need for real-time monitoring and more personalized treatment options for patients. Companies are introducing devices with features such as remote monitoring, automatic insulin delivery, and integration with smartphones to enhance user convenience and improve patient outcomes. To maintain a competitive edge, market leaders also engage in strategic partnerships, collaborations, and acquisitions, expanding their product portfolios and geographical reach. The increasing demand for integrated diabetes management solutions and a focus on improving patient adherence are key factors pushing companies to develop more user-friendly and efficient devices. The competitive landscape is also influenced by regulatory challenges, pricing pressures, and the need to comply with regional health standards. As the market continues to grow, companies must innovate while addressing these challenges to stay relevant in the rapidly evolving diabetes care industry.

Recent Developments

  • In October 2024, Glooko secured a USD 100 million investment aimed at expanding its diabetes management system. The funding was intended to enhance the company’s reach across North America, as well as the Middle East and Asia.
  • In August 2024, Medtronic announced its partnership with Abbott, which was expected to improve its struggling diabetes care segment by integrating advanced glucose monitoring technology, enhancing their offerings and potentially strengthening Medtronic’s position in the market.
  • In March 2024, Dexcom introduced its newest CGM system, Dexcom ONE+, in Ireland. Dexcom ONE+ utilizes Dexcom’s top-tier and highly accurate sensor design. This product launch will bolster the company’s product portfolio in the Irish market and is expected to boost the company’s revenue.
  • In May 2023, Medtronic agreed to acquire EOFlow, a manufacturer of insulin devices. The integration of EOFlow with Medtronic’s Meal Detection Technology algorithm and advanced continuous glucose monitor (CGM) is expected to enhance the company’s ability to serve a broader range of people with diabetes
  • In April 2023, Undbio announced its plan to invest USD 100 million in constructing a US-based insulin manufacturing plant. The South Korean company intends to build a new facility in West Virginia to manufacture insulin and distribute its products within the country
  • In July 2023, CharmHealth and Bioverge jointly invested in My Diabetes Tutor, a startup focused on improving the lives of individuals with diabetes

Market Concentration & Characteristics

The global diabetes care devices market exhibits moderate to high concentration, with several key players dominating the landscape. These companies invest heavily in research and development to create innovative solutions, such as continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. Market concentration is further fueled by strategic mergers, acquisitions, and partnerships, which allow these players to expand their product offerings and reach new markets. While a few large corporations hold significant market shares, the market also has room for smaller, specialized players focusing on niche segments or regional markets. The competitive dynamics in this industry are shaped by factors like technological innovation, regulatory hurdles, and pricing strategies.

The characteristics of the diabetes care devices market include rapid technological advancements and a strong emphasis on patient-centered solutions. Companies are increasingly developing devices with features such as real-time monitoring, automated insulin delivery, and seamless integration with digital platforms. Moreover, the market is characterized by growing consumer demand for more convenient, user-friendly products, which has led to the emergence of smart devices and mobile applications for diabetes management. As the global diabetic population rises, market players must address the needs of diverse demographics, with a focus on improving accessibility, affordability, and overall patient outcomes.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, Monitoring Devices, Delivery Devices, Indication, End-Users and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The global diabetes care devices market is expected to experience significant growth, driven by the increasing prevalence of diabetes worldwide.
  2. Technological advancements such as continuous glucose monitoring (CGM) and insulin pumps will continue to shape the future of diabetes management.
  3. The integration of AI and machine learning into diabetes devices will enhance personalized treatment options for patients.
  4. Smart insulin pens and mobile health apps will become more prevalent, offering greater convenience and better treatment adherence.
  5. The demand for affordable and accessible diabetes care solutions will grow, especially in emerging markets.
  6. The growing adoption of remote patient monitoring and telehealth consultations will make diabetes care more convenient for patients globally.
  7. Increasing awareness about diabetes prevention and management will fuel the need for advanced devices and tools.
  8. Regulatory frameworks will evolve to accommodate innovations in diabetes care, ensuring patient safety while enabling faster market entry.
  9. The aging population will drive demand for diabetes care devices, as older adults are at higher risk for type 2 diabetes.
  10. Strategic collaborations, mergers, and acquisitions among key players will continue to consolidate the market and expand product portfolios.

CHAPTER NO. 1 : INTRODUCTION 32
1.1.1. Report Description 32
Purpose of the Report 32
USP & Key Offerings 32
1.1.2. Key Benefits for Stakeholders 32
1.1.3. Target Audience 33
1.1.4. Report Scope 33
1.1.5. Regional Scope 34
CHAPTER NO. 2 : EXECUTIVE SUMMARY 35
2.1. DIABETES CARE DEVICES Market Snapshot 35
2.1.1. Global DIABETES CARE DEVICES Market, 2018 – 2032 (USD Million) 36
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 37
3.1. Russia-Ukraine and Israel-Palestine War Impacts 37
CHAPTER NO. 4 : DIABETES CARE DEVICES MARKET – INDUSTRY ANALYSIS 38
4.1. Introduction 38
4.2. Market Drivers 39
4.2.1. Increasing incidence of Diabetes in Asia 39
4.2.2. Unhealthy life style and habits increasing the risks of Diabetes 40
4.3. Market Restraints 41
4.3.1. Invasive technologies increasing the risk of infection 41
4.4. Market Opportunities 42
4.4.1. Market Opportunity Analysis 42
4.5. Porter’s Five Forces Analysis 43
4.6. Value Chain Analysis 44
4.7. Buying Criteria 45
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 46
5.1. Import Analysis by Region 46
5.1.1. Global DIABETES CARE DEVICES Market Import Volume/Revenue, By Region, 2018 – 2023 46
5.2. Export Analysis by Region 47
5.2.1. Global DIABETES CARE DEVICES Market Export Volume/Revenue, By Region, 2018 – 2023 47
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 48
6.1. Demand Analysis by Region 48
6.1.1. Global DIABETES CARE DEVICES Market Demand Volume/Revenue, By Region, 2018 – 2023 48
6.2. Supply Analysis by Region 49
6.2.1. Global DIABETES CARE DEVICES Market Supply Volume/Revenue, By Region, 2018 – 2023 49
CHAPTER NO. 7 : PRODUCTION ANALYSIS 50
7.1. Production Analysis by Region 50
7.1.1. Global DIABETES CARE DEVICES Market Production Volume/Revenue, By Region, 2018 – 2023 50
CHAPTER NO. 8 : PRICE ANALYSIS 51
8.1. Price Analysis by Region 51
8.1.1. Global DIABETES CARE DEVICES Market Price, By Region, 2018 – 2023 51
8.1.2. Global Type Market Price, By Region, 2018 – 2023 51
8.2. Price Analysis by Type 52
8.2.1. Global DIABETES CARE DEVICES Market Price, By Type, 2018 – 2023 52
8.2.2. Global Type Market Price, By Type, 2018 – 2023 52
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 53
9.1. Key Raw Materials and Suppliers 53
9.2. Key Raw Materials Price Trend 53
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 54
10.1. Manufacturing Cost Analysis 54
10.2. Manufacturing Process 54
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 55
11.1. Company Market Share Analysis – 2023 55
11.1.1. Global DIABETES CARE DEVICES Market: Company Market Share, by Volume, 2023 55
11.1.2. Global DIABETES CARE DEVICES Market: Company Market Share, by Revenue, 2023 56
11.1.3. Global DIABETES CARE DEVICES Market: Top 6 Company Market Share, by Revenue, 2023 56
11.1.4. Global DIABETES CARE DEVICES Market: Top 3 Company Market Share, by Revenue, 2023 57
11.2. Global DIABETES CARE DEVICES Market Company Volume Market Share, 2023 58
11.3. Global DIABETES CARE DEVICES Market Company Revenue Market Share, 2023 59
11.4. Company Assessment Metrics, 2023 60
11.4.1. Stars 60
11.4.2. Emerging Leaders 60
11.4.3. Pervasive Players 60
11.4.4. Participants 60
11.5. Start-ups /SMEs Assessment Metrics, 2023 60
11.5.1. Progressive Companies 60
11.5.2. Responsive Companies 60
11.5.3. Dynamic Companies 60
11.5.4. Starting Blocks 60
11.6. Strategic Developments 61
11.6.1. Acquisitions & Mergers 61
New Product Launch 61
Regional Expansion 61
11.7. Key Players Product Matrix 62
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 63
12.1. PESTEL 63
12.1.1. Political Factors 63
12.1.2. Economic Factors 63
12.1.3. Social Factors 63
12.1.4. Technological Factors 63
12.1.5. Environmental Factors 63
12.1.6. Legal Factors 63
12.2. Adjacent Market Analysis 63
CHAPTER NO. 13 : DIABETES CARE DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 64
13.1. DIABETES CARE DEVICES Market Overview, by Type Segment 64
13.1.1. DIABETES CARE DEVICES Market Revenue Share, By Type, 2023 & 2032 65
13.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Type 66
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 66
13.1.4. DIABETES CARE DEVICES Market Revenue, By Type, 2018, 2023, 2027 & 2032 67
13.2. Monitoring 68
13.2.1. Global Monitoring DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 69
13.2.2. Global Monitoring DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 69
13.3. Delivery 70
13.3.1. Global Delivery DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 71
13.3.2. Global Delivery DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 71
CHAPTER NO. 14 : DIABETES CARE DEVICES MARKET – BY MONITORING DEVICES SEGMENT ANALYSIS 72
14.1. DIABETES CARE DEVICES Market Overview, by Monitoring Devices Segment 72
14.1.1. DIABETES CARE DEVICES Market Revenue Share, By Monitoring Devices, 2023 & 2032 73
14.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Monitoring Devices 74
14.1.3. Incremental Revenue Growth Opportunity, by Monitoring Devices, 2024 – 2032 74
14.1.4. DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018, 2023, 2027 & 2032 75
14.2. Continuous Monitoring Devices 76
14.2.1. Global Continuous Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 77
14.2.2. Global Continuous Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 77
14.3. Lancets 78
14.3.1. Global Lancets DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 79
14.3.2. Global Lancets DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 79
14.4. Test Strips 80
14.4.1. Global Test Strips DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 81
14.4.2. Global Test Strips DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 81
14.5. Self Monitoring Devices 82
14.5.1. Global Self Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 83
14.5.2. Global Self Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 83
14.6. Monitoring Devices 5 84
14.6.1. Global Monitoring Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 85
14.6.2. Global Monitoring Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 85
CHAPTER NO. 15 : DIABETES CARE DEVICES MARKET – BY DELIVERY DEVICES SEGMENT ANALYSIS 86
15.1. DIABETES CARE DEVICES Market Overview, by Delivery Devices Segment 86
15.1.1. DIABETES CARE DEVICES Market Revenue Share, By Delivery Devices, 2023 & 2032 87
15.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Delivery Devices 88
15.1.3. Incremental Revenue Growth Opportunity, by Delivery Devices, 2024 – 2032 88
15.1.4. DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018, 2023, 2027 & 2032 89
15.2. Insulin Pumps 90
15.2.1. Global Insulin Pumps DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 91
15.2.2. Global Insulin Pumps DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 91
15.3. Pens 92
15.3.1. Global Pens DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 93
15.3.2. Global Pens DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 93
15.4. Syringes 94
15.4.1. Global Syringes DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 95
15.4.2. Global Syringes DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 95
15.5. Needles 96
15.5.1. Global Needles DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 97
15.5.2. Global Needles DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 97
15.6. Delivery Devices 5 98
15.6.1. Global Delivery Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 99
15.6.2. Global Delivery Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 99
CHAPTER NO. 16 : DIABETES CARE DEVICES MARKET – BY INDICATION SEGMENT ANALYSIS 100
16.1. DIABETES CARE DEVICES Market Overview, by Indication Segment 100
16.1.1. DIABETES CARE DEVICES Market Revenue Share, By Indication, 2023 & 2032 101
16.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Indication 102
16.1.3. Incremental Revenue Growth Opportunity, by Indication, 2024 – 2032 102
16.1.4. DIABETES CARE DEVICES Market Revenue, By Indication, 2018, 2023, 2027 & 2032 103
16.2. Diabetes Type I 104
16.2.1. Global Diabetes Type I DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 105
16.2.2. Global Diabetes Type I DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 105
16.3. Diabetes Type II 106
16.3.1. Global Diabetes Type II DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 107
16.3.2. Global Diabetes Type II DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 107
16.4. Gestational Diabetes 108
16.4.1. Global Gestational Diabetes DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 109
16.4.2. Global Gestational Diabetes DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 109
16.5. Indication 4 110
16.5.1. Global Indication 4 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 111
16.5.2. Global Indication 4 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 111
16.6. Indication 5 112
16.6.1. Global Indication 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 113
16.6.2. Global Indication 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 113
CHAPTER NO. 17 : DIABETES CARE DEVICES MARKET – BY END-USERS SEGMENT ANALYSIS 114
17.1. DIABETES CARE DEVICES Market Overview, by End-Users Segment 114
17.1.1. DIABETES CARE DEVICES Market Revenue Share, By End-Users, 2023 & 2032 115
17.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By End-Users 116
17.1.3. Incremental Revenue Growth Opportunity, by End-Users, 2024 – 2032 116
17.1.4. DIABETES CARE DEVICES Market Revenue, By End-Users, 2018, 2023, 2027 & 2032 117
17.2. Hospital Pharmacies 118
17.2.1. Global Hospital Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 119
17.2.2. Global Hospital Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 119
17.3. Retail Pharmacies 120
17.3.1. Global Retail Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 121
17.3.2. Global Retail Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 121
17.4. Online Pharmacies 122
17.4.1. Global Online Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 123
17.4.2. Global Online Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 123
CHAPTER NO. 18 : DIABETES CARE DEVICES MARKET – REGIONAL ANALYSIS 125
18.1. DIABETES CARE DEVICES Market Overview, by Regional Segments 125
18.2. Region 126
18.2.1. Global DIABETES CARE DEVICES Market Revenue Share, By Region, 2023 & 2032 126
18.2.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Region 127
18.2.3. Incremental Revenue Growth Opportunity, by Region, 2024 – 2032 127
18.2.4. DIABETES CARE DEVICES Market Revenue, By Region, 2018, 2023, 2027 & 2032 128
18.2.5. Global DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 129
18.2.6. Global DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 129
18.3. Type 130
18.3.1. Global DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 130
18.4. Global DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 130
18.5. Monitoring Devices 131
18.5.1. Global DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 131
18.5.2. Global DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 131
18.6. Delivery Devices 132
18.6.1. Global DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 132
18.6.2. Global DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 132
18.7. Indication 133
18.7.1. Global DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 133
18.7.2. Global DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 133
18.8. End-Users 134
18.8.1. Global DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 134
18.8.2. Global DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 134
CHAPTER NO. 19 : DIABETES CARE DEVICES MARKET – NORTH AMERICA 135
19.1. North America 135
19.1.1. Key Highlights 135
19.1.2. North America DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 136
19.1.3. North America DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 137
19.1.4. North America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 138
19.1.5. North America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 139
19.1.6. North America DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 140
19.1.7. North America DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 141
19.2. U.S. 142
19.3. Canada 142
19.4. Mexico 142
CHAPTER NO. 20 : DIABETES CARE DEVICES MARKET – EUROPE 143
20.1. Europe 143
20.1.1. Key Highlights 143
20.1.2. Europe DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 144
20.1.3. Europe DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 145
20.1.4. Europe DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 146
20.1.5. Europe DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 147
20.1.6. Europe DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 148
20.1.7. Europe DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 149
20.2. UK 150
20.3. France 150
20.4. Germany 150
20.5. Italy 150
20.6. Spain 150
20.7. Russia 150
20.8. Belgium 150
20.9. Netherland 150
20.10. Austria 150
20.11. Sweden 150
20.12. Poland 150
20.13. Denmark 150
20.14. Switzerland 150
20.15. Rest of Europe 150
CHAPTER NO. 21 : DIABETES CARE DEVICES MARKET – ASIA PACIFIC 151
21.1. Asia Pacific 151
21.1.1. Key Highlights 151
21.1.2. Asia Pacific DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 152
21.1.3. Asia Pacific DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 153
21.1.4. Asia Pacific DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 154
21.1.5. Asia Pacific DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 155
21.1.6. Asia Pacific DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 156
21.1.7. Asia Pacific DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 157
21.2. China 158
21.3. Japan 158
21.4. South Korea 158
21.5. India 158
21.6. Australia 158
21.7. Thailand 158
21.8. Indonesia 158
21.9. Vietnam 158
21.10. Malaysia 158
21.11. Philippines 158
21.12. Taiwan 158
21.13. Rest of Asia Pacific 158
CHAPTER NO. 22 : DIABETES CARE DEVICES MARKET – LATIN AMERICA 159
22.1. Latin America 159
22.1.1. Key Highlights 159
22.1.2. Latin America DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 160
22.1.3. Latin America DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 161
22.1.4. Latin America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 162
22.1.5. Latin America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 163
22.1.6. Latin America DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 164
22.1.7. Latin America DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 165
22.2. Brazil 166
22.3. Argentina 166
22.4. Peru 166
22.5. Chile 166
22.6. Colombia 166
22.7. Rest of Latin America 166
CHAPTER NO. 23 : DIABETES CARE DEVICES MARKET – MIDDLE EAST 167
23.1. Middle East 167
23.1.1. Key Highlights 167
23.1.2. Middle East DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 168
23.1.3. Middle East DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 169
23.1.4. Middle East DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 170
23.1.5. Middle East DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 171
23.1.6. Middle East DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 172
23.1.7. Middle East DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 173
23.2. UAE 174
23.3. KSA 174
23.4. Israel 174
23.5. Turkey 174
23.6. Iran 174
23.7. Rest of Middle East 174
CHAPTER NO. 24 : DIABETES CARE DEVICES MARKET – AFRICA 175
24.1. Africa 175
24.1.1. Key Highlights 175
24.1.2. Africa DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 176
24.1.3. Africa DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 177
24.1.4. Africa DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 178
24.1.5. Africa DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 179
24.1.6. Africa DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 180
24.1.7. Africa DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 181
24.2. Egypt 182
24.3. Nigeria 182
24.4. Algeria 182
24.5. Morocco 182
24.6. Rest of Africa 182
CHAPTER NO. 25 : COMPANY PROFILES 183
25.1. Abbott Laboratories 183
25.1.1. Company Overview 183
25.1.2. Product Portfolio 183
25.1.3. Swot Analysis 183
25.1.4. Business Strategy 184
25.1.5. Financial Overview 184
25.2. ACON Laboratories, Inc. 185
25.3. Ascensia Diabetes Care Holdings AG 185
25.4. Becton, Dickinson and Company 185
25.5. Dexcom, Inc. 185
25.6. F. Hoffmann-La Roche Ltd 185
25.7. Johnson & Johnson 185
25.8. Medtronic plc 185
25.9. Novo Nordisk A/S 185
25.10. Terumo Corporation 185
25.11. Company 11 185
25.12. Company 12 185
25.13. Company 13 185
25.14. Company 14 185

List of Figures
FIG NO. 1. Global DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 37
FIG NO. 2. Porter’s Five Forces Analysis for Global DIABETES CARE DEVICES Market 44
FIG NO. 3. Value Chain Analysis for Global DIABETES CARE DEVICES Market 45
FIG NO. 4. Global DIABETES CARE DEVICES Market Import Volume/Revenue, By Region, 2018 – 2023 47
FIG NO. 5. Global DIABETES CARE DEVICES Market Export Volume/Revenue, By Region, 2018 – 2023 48
FIG NO. 6. Global DIABETES CARE DEVICES Market Demand Volume/Revenue, By Region, 2018 – 2023 49
FIG NO. 7. Global DIABETES CARE DEVICES Market Supply Volume/Revenue, By Region, 2018 – 2023 50
FIG NO. 8. Global DIABETES CARE DEVICES Market Production Volume/Revenue, By Region, 2018 – 2023 51
FIG NO. 9. Global DIABETES CARE DEVICES Market Price, By Region, 2018 – 2023 52
FIG NO. 10. Global DIABETES CARE DEVICES Market Price, By Type, 2018 – 2023 53
FIG NO. 11. Raw Materials Price Trend Analysis, 2018 – 2023 54
FIG NO. 12. Manufacturing Cost Analysis 55
FIG NO. 13. Manufacturing Process 55
FIG NO. 14. Company Share Analysis, 2023 56
FIG NO. 15. Company Share Analysis, 2023 57
FIG NO. 16. Company Share Analysis, 2023 57
FIG NO. 17. Company Share Analysis, 2023 58
FIG NO. 18. DIABETES CARE DEVICES Market – Company Volume Market Share, 2023 59
FIG NO. 19. DIABETES CARE DEVICES Market – Company Revenue Market Share, 2023 60
FIG NO. 20. DIABETES CARE DEVICES Market Revenue Share, By Type, 2023 & 2032 66
FIG NO. 21. Market Attractiveness Analysis, By Type 67
FIG NO. 22. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 67
FIG NO. 23. DIABETES CARE DEVICES Market Revenue, By Type, 2018, 2023, 2027 & 2032 68
FIG NO. 24. Global DIABETES CARE DEVICES Market for Monitoring, Revenue (USD Million) 2018 – 2032 69
FIG NO. 25. Global DIABETES CARE DEVICES Market for Delivery, Revenue (USD Million) 2018 – 2032 71
FIG NO. 26. Global DIABETES CARE DEVICES Market for Type 3, Revenue (USD Million) 2018 – 2032 73
FIG NO. 27. Global DIABETES CARE DEVICES Market for Type 4, Revenue (USD Million) 2018 – 2032 75
FIG NO. 28. Global DIABETES CARE DEVICES Market for Type 5, Revenue (USD Million) 2018 – 2032 77
FIG NO. 29. DIABETES CARE DEVICES Market Revenue Share, By Monitoring Devices, 2023 & 2032 80
FIG NO. 30. Market Attractiveness Analysis, By Monitoring Devices 81
FIG NO. 31. Incremental Revenue Growth Opportunity by Monitoring Devices, 2024 – 2032 81
FIG NO. 32. DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018, 2023, 2027 & 2032 82
FIG NO. 33. Global DIABETES CARE DEVICES Market for Continuous Monitoring Devices , Revenue (USD Million) 2018 – 2032 83
FIG NO. 34. Global DIABETES CARE DEVICES Market for Lancets, Revenue (USD Million) 2018 – 2032 85
FIG NO. 35. Global DIABETES CARE DEVICES Market for Test Strips, Revenue (USD Million) 2018 – 2032 87
FIG NO. 36. Global DIABETES CARE DEVICES Market for Self Monitoring Devices , Revenue (USD Million) 2018 – 2032 89
FIG NO. 37. Global DIABETES CARE DEVICES Market for Monitoring Devices 5, Revenue (USD Million) 2018 – 2032 91
FIG NO. 38. DIABETES CARE DEVICES Market Revenue Share, By Delivery Devices, 2023 & 2032 94
FIG NO. 39. Market Attractiveness Analysis, By Delivery Devices 95
FIG NO. 40. Incremental Revenue Growth Opportunity by Delivery Devices, 2024 – 2032 95
FIG NO. 41. DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018, 2023, 2027 & 2032 96
FIG NO. 42. Global DIABETES CARE DEVICES Market for Insulin Pumps, Revenue (USD Million) 2018 – 2032 97
FIG NO. 43. Global DIABETES CARE DEVICES Market for Pens, Revenue (USD Million) 2018 – 2032 99
FIG NO. 44. Global DIABETES CARE DEVICES Market for Syringes, Revenue (USD Million) 2018 – 2032 101
FIG NO. 45. Global DIABETES CARE DEVICES Market for Needles, Revenue (USD Million) 2018 – 2032 103
FIG NO. 46. Global DIABETES CARE DEVICES Market for Delivery Devices 5, Revenue (USD Million) 2018 – 2032 105
FIG NO. 47. DIABETES CARE DEVICES Market Revenue Share, By Indication, 2023 & 2032 108
FIG NO. 48. Market Attractiveness Analysis, By Indication 109
FIG NO. 49. Incremental Revenue Growth Opportunity by Indication, 2024 – 2032 109
FIG NO. 50. DIABETES CARE DEVICES Market Revenue, By Indication, 2018, 2023, 2027 & 2032 110
FIG NO. 51. Global DIABETES CARE DEVICES Market for Diabetes Type I, Revenue (USD Million) 2018 – 2032 111
FIG NO. 52. Global DIABETES CARE DEVICES Market for Diabetes Type II, Revenue (USD Million) 2018 – 2032 113
FIG NO. 53. Global DIABETES CARE DEVICES Market for Gestational Diabetes, Revenue (USD Million) 2018 – 2032 115
FIG NO. 54. Global DIABETES CARE DEVICES Market for Indication 4, Revenue (USD Million) 2018 – 2032 117
FIG NO. 55. Global DIABETES CARE DEVICES Market for Indication 5, Revenue (USD Million) 2018 – 2032 119
FIG NO. 56. DIABETES CARE DEVICES Market Revenue Share, By End-Users, 2023 & 2032 122
FIG NO. 57. Market Attractiveness Analysis, By End-Users 123
FIG NO. 58. Incremental Revenue Growth Opportunity by End-Users, 2024 – 2032 123
FIG NO. 59. DIABETES CARE DEVICES Market Revenue, By End-Users, 2018, 2023, 2027 & 2032 124
FIG NO. 60. Global DIABETES CARE DEVICES Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 125
FIG NO. 61. Global DIABETES CARE DEVICES Market for Retail Pharmacies, Revenue (USD Million) 2018 – 2032 127
FIG NO. 62. Global DIABETES CARE DEVICES Market for Online Pharmacies, Revenue (USD Million) 2018 – 2032 129
FIG NO. 63. Global DIABETES CARE DEVICES Market for End-Users 4, Revenue (USD Million) 2018 – 2032 131
FIG NO. 64. Global DIABETES CARE DEVICES Market for End-Users 5, Revenue (USD Million) 2018 – 2032 133
FIG NO. 65. Global DIABETES CARE DEVICES Market Revenue Share, By Region, 2023 & 2032 136
FIG NO. 66. Market Attractiveness Analysis, By Region 137
FIG NO. 67. Incremental Revenue Growth Opportunity by Region, 2024 – 2032 137
FIG NO. 68. DIABETES CARE DEVICES Market Revenue, By Region, 2018, 2023, 2027 & 2032 138
FIG NO. 69. North America DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 145
FIG NO. 70. Europe DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 153
FIG NO. 71. Asia Pacific DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 161
FIG NO. 72. Latin America DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 169
FIG NO. 73. Middle East DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 177
FIG NO. 74. Africa DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 185
FIG NO. 75. Research Methodology – Detailed View Error! Bookmark not defined.
FIG NO. 76. Research Methodology Error! Bookmark not defined.

List of Tables
TABLE NO. 1. : Global DIABETES CARE DEVICES Market: Snapshot 36
TABLE NO. 2. : Drivers for the DIABETES CARE DEVICES Market: Impact Analysis 40
TABLE NO. 3. : Restraints for the DIABETES CARE DEVICES Market: Impact Analysis 42
TABLE NO. 4. : Global DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 52
TABLE NO. 5. : Global DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 53
TABLE NO. 6. : Key Raw Materials & Suppliers 54
TABLE NO. 7. : Global Monitoring DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 70
TABLE NO. 8. : Global Monitoring DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 70
TABLE NO. 9. : Global Delivery DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 72
TABLE NO. 10. : Global Delivery DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 72
TABLE NO. 11. : Global Type 3 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 74
TABLE NO. 12. : Global Type 3 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 74
TABLE NO. 13. : Global Type 4 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 76
TABLE NO. 14. : Global Type 4 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 76
TABLE NO. 15. : Global Type 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 78
TABLE NO. 16. : Global Type 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 78
TABLE NO. 17. : Global Continuous Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 84
TABLE NO. 18. : Global Continuous Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 84
TABLE NO. 19. : Global Lancets DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 86
TABLE NO. 20. : Global Lancets DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 86
TABLE NO. 21. : Global Test Strips DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 88
TABLE NO. 22. : Global Test Strips DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 88
TABLE NO. 23. : Global Self Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 90
TABLE NO. 24. : Global Self Monitoring Devices DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 90
TABLE NO. 25. : Global Monitoring Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 92
TABLE NO. 26. : Global Monitoring Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 92
TABLE NO. 27. : Global Insulin Pumps DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 98
TABLE NO. 28. : Global Insulin Pumps DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 98
TABLE NO. 29. : Global Pens DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 100
TABLE NO. 30. : Global Pens DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 100
TABLE NO. 31. : Global Syringes DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 102
TABLE NO. 32. : Global Syringes DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 102
TABLE NO. 33. : Global Needles DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 104
TABLE NO. 34. : Global Needles DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 104
TABLE NO. 35. : Global Delivery Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 106
TABLE NO. 36. : Global Delivery Devices 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 106
TABLE NO. 37. : Global Diabetes Type I DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 112
TABLE NO. 38. : Global Diabetes Type I DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 112
TABLE NO. 39. : Global Diabetes Type II DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 114
TABLE NO. 40. : Global Diabetes Type II DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 114
TABLE NO. 41. : Global Gestational Diabetes DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 116
TABLE NO. 42. : Global Gestational Diabetes DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 116
TABLE NO. 43. : Global Indication 4 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 118
TABLE NO. 44. : Global Indication 4 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 118
TABLE NO. 45. : Global Indication 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 120
TABLE NO. 46. : Global Indication 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 120
TABLE NO. 47. : Global Hospital Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 126
TABLE NO. 48. : Global Hospital Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 126
TABLE NO. 49. : Global Retail Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 128
TABLE NO. 50. : Global Retail Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 128
TABLE NO. 51. : Global Online Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 130
TABLE NO. 52. : Global Online Pharmacies DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 130
TABLE NO. 53. : Global End-Users 4 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 132
TABLE NO. 54. : Global End-Users 4 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 132
TABLE NO. 55. : Global End-Users 5 DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 134
TABLE NO. 56. : Global End-Users 5 DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 134
TABLE NO. 57. : Global DIABETES CARE DEVICES Market Revenue, By Region, 2018 – 2023 (USD Million) 139
TABLE NO. 58. : Global DIABETES CARE DEVICES Market Revenue, By Region, 2024 – 2032 (USD Million) 139
TABLE NO. 59. : Global DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 140
TABLE NO. 60. : Global DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 140
TABLE NO. 61. : Global DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 141
TABLE NO. 62. : Global DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 141
TABLE NO. 63. : Global DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 142
TABLE NO. 64. : Global DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 142
TABLE NO. 65. : Global DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 143
TABLE NO. 66. : Global DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 143
TABLE NO. 67. : Global DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 144
TABLE NO. 68. : Global DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 144
TABLE NO. 69. : North America DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 146
TABLE NO. 70. : North America DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 146
TABLE NO. 71. : North America DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 147
TABLE NO. 72. : North America DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 147
TABLE NO. 73. : North America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 148
TABLE NO. 74. : North America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 148
TABLE NO. 75. : North America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 149
TABLE NO. 76. : North America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 149
TABLE NO. 77. : North America DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 150
TABLE NO. 78. : North America DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 150
TABLE NO. 79. : North America DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 151
TABLE NO. 80. : North America DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 151
TABLE NO. 81. : Europe DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 154
TABLE NO. 82. : Europe DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 154
TABLE NO. 83. : Europe DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 155
TABLE NO. 84. : Europe DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 155
TABLE NO. 85. : Europe DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 156
TABLE NO. 86. : Europe DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 156
TABLE NO. 87. : Europe DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 157
TABLE NO. 88. : Europe DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 157
TABLE NO. 89. : Europe DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 158
TABLE NO. 90. : Europe DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 158
TABLE NO. 91. : Europe DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 159
TABLE NO. 92. : Europe DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 159
TABLE NO. 93. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 162
TABLE NO. 94. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 162
TABLE NO. 95. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 163
TABLE NO. 96. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 163
TABLE NO. 97. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 164
TABLE NO. 98. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 164
TABLE NO. 99. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 165
TABLE NO. 100. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 165
TABLE NO. 101. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 166
TABLE NO. 102. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 166
TABLE NO. 103. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 167
TABLE NO. 104. : Asia Pacific DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 167
TABLE NO. 105. : Latin America DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 170
TABLE NO. 106. : Latin America DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 170
TABLE NO. 107. : Latin America DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 171
TABLE NO. 108. : Latin America DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 171
TABLE NO. 109. : Latin America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 172
TABLE NO. 110. : Latin America DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 172
TABLE NO. 111. : Latin America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 173
TABLE NO. 112. : Latin America DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 173
TABLE NO. 113. : Latin America DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 174
TABLE NO. 114. : Latin America DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 174
TABLE NO. 115. : Latin America DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 175
TABLE NO. 116. : Latin America DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 175
TABLE NO. 117. : Middle East DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 178
TABLE NO. 118. : Middle East DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 178
TABLE NO. 119. : Middle East DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 179
TABLE NO. 120. : Middle East DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 179
TABLE NO. 121. : Middle East DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 180
TABLE NO. 122. : Middle East DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 180
TABLE NO. 123. : Middle East DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 181
TABLE NO. 124. : Middle East DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 181
TABLE NO. 125. : Middle East DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 182
TABLE NO. 126. : Middle East DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 182
TABLE NO. 127. : Middle East DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 183
TABLE NO. 128. : Middle East DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 183
TABLE NO. 129. : Africa DIABETES CARE DEVICES Market Revenue, By Country, 2018 – 2023 (USD Million) 186
TABLE NO. 130. : Africa DIABETES CARE DEVICES Market Revenue, By Country, 2024 – 2032 (USD Million) 186
TABLE NO. 131. : Africa DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 187
TABLE NO. 132. : Africa DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 187
TABLE NO. 133. : Africa DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2018 – 2023 (USD Million) 188
TABLE NO. 134. : Africa DIABETES CARE DEVICES Market Revenue, By Monitoring Devices, 2024 – 2032 (USD Million) 188
TABLE NO. 135. : Africa DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2018 – 2023 (USD Million) 189
TABLE NO. 136. : Africa DIABETES CARE DEVICES Market Revenue, By Delivery Devices, 2024 – 2032 (USD Million) 189
TABLE NO. 137. : Africa DIABETES CARE DEVICES Market Revenue, By Indication, 2018 – 2023 (USD Million) 190
TABLE NO. 138. : Africa DIABETES CARE DEVICES Market Revenue, By Indication, 2024 – 2032 (USD Million) 190
TABLE NO. 139. : Africa DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 191
TABLE NO. 140. : Africa DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 191

Frequently Asked Questions:

What is the current size of the Global Diabetes Care Devices Market?

The global diabetes care devices market was valued at USD 31,762.94 million in 2023 and is projected to reach USD 35,638.02 million by 2032, growing at a compound annual growth rate (CAGR) of 5.37%.

What factors are driving the growth of the Global Diabetes Care Devices Market?

Growth is driven by the increasing prevalence of diabetes worldwide, advancements in technologies such as continuous glucose monitoring (CGM) systems and insulin pumps, and rising adoption of home care solutions. Government initiatives, improved awareness of diabetes management, and integration of devices with telehealth and wearables are additional contributing factors.

What are the key segments within the Global Diabetes Care Devices Market?

The market is segmented into Monitoring Devices (including continuous monitoring devices, lancets, test strips, and self-monitoring devices) and Delivery Devices (such as insulin pumps, pens, syringes, and needles). It is also categorized by indication (type 1 diabetes, type 2 diabetes, gestational diabetes) and end-users (hospital pharmacies, retail pharmacies, online pharmacies).

What are some challenges faced by the Global Diabetes Care Devices Market?

Challenges include the high cost of advanced devices, limited reimbursement policies, stringent regulatory frameworks, and technical issues like data security concerns and device accuracy. Inadequate healthcare infrastructure and accessibility barriers, especially in low- and middle-income regions, further constrain market growth.

Who are the major players in the Global Diabetes Care Devices Market?

Key players include Abbott Laboratories, ACON Laboratories, Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, and Terumo Corporation. These companies focus on innovation, strategic collaborations, and expanding product portfolios to address diverse patient needs.

Mexico Diabetes Care Devices Market

Published:
Report ID: 65524

United States Diabetes Care Devices Market

Published:
Report ID: 65380

Turkey Diabetes Care Devices Market

Published:
Report ID: 65238

Switzerland Diabetes Care Devices Market

Published:
Report ID: 65249

UAE Diabetes Care Devices Market

Published:
Report ID: 65164

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Spain Diabetes Care Devices Market

Published:
Report ID: 64535

Canada Diabetes Care Devices Market

Published:
Report ID: 64378

United Kingdom Diabetes Care Devices Market

Published:
Report ID: 64238

Non-Invasive Brain Stimulation System Market

Published:
Report ID: 70014

Intraoperative Fluorescence Imaging Market

Published:
Report ID: 69969

Latin America Peripheral Vascular Devices Market

Published:
Report ID: 69958

Vietnam Medical Gas and Equipment Market

Published:
Report ID: 69935

Indonesia Medical Gas and Equipment Market

Published:
Report ID: 69932

UAE Peripheral Vascular Devices Market

Published:
Report ID: 69875

Africa Medical Gas and Equipment Market

Published:
Report ID: 69866

South Korea Peritoneal Dialysis Market

Published:
Report ID: 69854

Personal Emergency Response System Market

Published:
Report ID: 69771

Patient Positioning Equipment Market

Published:
Report ID: 69757

United Kingdom Digital Radiography Market

Published:
Report ID: 69747

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN